// App-Quantinova.ai

: Late Breaking Abstract - Efficacy of DPP1 inhibition with brensocatib in subgroups of patients with bronchiectasis- the WILLOW study

Researchers

Presenter

  • James D. Chalmers

Principal Investigators

  • Charles Haworth

  • Mark Metersky

  • Michael Loebinger

  • Francesco Blasi

  • Oriol Sibila

  • Anne O'Donnell

  • Eugene Sullivan

  • Kevin Mange

  • Carlos Fernandez

  • Jun Zou

  • Charles Daley

Medical Centers

  • University of Dundee, Dundee, United Kingdom

  • Papworth Hospital, Cambridge, United Kingdom

  • University of Connecticut, Rheumatology, Farmington, United States of America

  • Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom

  • University of Milan, Milan, Italy

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Insmed, Bridgewater, NJ, United States of America

  • National Jewish Health and the University of Colorado, Dundee (Angus, United States of America

Locations

  • United Kingdom

  • United States

  • Italy

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Dipeptidyl peptidase 1

Drug/Treatment

  • Elaszym

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • II

Study Id's

  • NCT03218917

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved